Acadia Healthcare Company, Inc. Forecast, price target & analysts
Acadia Healthcare Company, Inc. Target price 2025 - Analyst rating & recommendation
Acadia Healthcare Company, Inc. Classifications & Recommendation:
Acadia Healthcare Company, Inc. Price Target
| Target Price | $40.80 |
| Price | $21.90 |
| Potential |
86.30%
register free of charge
|
| Number of Estimates | 16 |
|
16 Analysts have issued a price target Acadia Healthcare Company, Inc. 2026 .
The average Acadia Healthcare Company, Inc. target price is $40.80.
This is
86.30%
register free of charge
$75.60
245.21%
register free of charge
$28.28
29.13%
register free of charge
|
|
| A rating was issued by 20 analysts: 15 Analysts recommend Acadia Healthcare Company, Inc. to buy, 5 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the Acadia Healthcare Company, Inc. stock has an average upside potential 2026 of
86.30%
register free of charge
|
Sales and Margin forecast 2025, 2026 to 2031
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Revenue Billion $ | 3.15 | 3.40 |
| 7.69% | 7.83% | |
| EBITDA Margin | 21.30% | 20.54% |
| 2.36% | 3.58% | |
| Net Margin | 8.10% | 7.13% |
| 1,195.33% | 12.02% |
16 Analysts have issued a sales forecast Acadia Healthcare Company, Inc. 2025 . The average Acadia Healthcare Company, Inc. sales estimate is
This results in the following potential growth metrics:
15 Analysts have issued an Acadia Healthcare Company, Inc. EBITDA forecast 2025. The average Acadia Healthcare Company, Inc. EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
16 Acadia Healthcare Company, Inc. Analysts have issued a net profit forecast 2025. The average Acadia Healthcare Company, Inc. net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 to 2031
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Earnings Per Share $ | 2.78 | 2.68 |
| 1,258.33% | 3.60% | |
| P/E | 8.17 | |
| EV/Sales | 1.21 |
16 Analysts have issued a Acadia Healthcare Company, Inc. forecast for earnings per share. The average Acadia Healthcare Company, Inc. EPS is
This results in the following potential growth metrics and future valuations:
Acadia Healthcare Company, Inc....
Current Acadia Healthcare Company, Inc. Upgrades & Downgrades
| Analyst | Rating | Action | Date |
|---|---|---|---|
| Barclays |
Locked
➜
Locked
|
Locked | May 14 2025 |
| Mizuho |
Locked
➜
Locked
|
Locked | May 14 2025 |
| Keybanc |
Locked
➜
Locked
|
Locked | May 14 2025 |
| Guggenheim |
Locked
➜
Locked
|
Locked | Apr 09 2025 |
| Mizuho |
Locked
➜
Locked
|
Locked | Mar 25 2025 |
| Keybanc |
Locked
➜
Locked
|
Locked | Mar 03 2025 |
| RBC Capital |
Locked
➜
Locked
|
Locked | Mar 03 2025 |
| Analyst Rating | Date |
|---|---|
|
Locked
Barclays:
Locked
➜
Locked
|
May 14 2025 |
|
Locked
Mizuho:
Locked
➜
Locked
|
May 14 2025 |
|
Locked
Keybanc:
Locked
➜
Locked
|
May 14 2025 |
|
Locked
Guggenheim:
Locked
➜
Locked
|
Apr 09 2025 |
|
Locked
Mizuho:
Locked
➜
Locked
|
Mar 25 2025 |
|
Locked
Keybanc:
Locked
➜
Locked
|
Mar 03 2025 |
|
Locked
RBC Capital:
Locked
➜
Locked
|
Mar 03 2025 |
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
